Oral Antiviral Drug Effective against Respiratory Syncytial Virus
These results lay a foundation and establish the clinical potential of the AVG inhibitor class
Source: labmanager.com
Stay updated with breaking news from John Vernachio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
These results lay a foundation and establish the clinical potential of the AVG inhibitor class
An oral antiviral drug that targets a key part of the respiratory syncytial virus (RSV) polymerase and inhibits the synthesis of viral genetic material has been identified, a finding that could provide an effective treatment against RSV disease, according to researchers in the Center for Translational Antiviral Research at Georgia State University.